Dermatomyositis
Dermatomyositis is a rare inflammatory disease characterized by muscle weakness and a distinctive skin rash. It affects the skin and muscles, leading to symptoms like difficulty in climbing stairs or lifting objects.
Filgotinib for Rare Immune Diseases
We are studying how filgotinib may improve quality of life and disease activity in patients with rare conditions like Behçet's disease, idiopathic inflammatory myopathy, and IgG4-related disease.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Antisynthetase Syndrome
Antisynthetase syndrome is a rare autoimmune condition that primarily affects the muscles and lungs, often associated with specific antibodies. Symptoms may include muscle weakness, lung issues, and skin rashes.
IgG4-Related Disease
IgG4-related disease is a rare condition characterized by inflammation and damage to various organs due to elevated levels of IgG4 antibodies. It can affect multiple systems in the body, leading to various symptoms.
Behcet's Disease
Behcet's disease is a rare autoimmune disorder that causes inflammation in blood vessels, leading to symptoms like mouth and genital ulcers, skin lesions, and eye inflammation.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Are you currently pregnant or breastfeeding?
- Do you have a history of substance abuse (drugs or alcohol)?
- Do you have any active infections or hepatitis?
- Do you have a life expectancy of less than 6 months?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC
Neurology
Amstelveen, Netherlands
University Medical Center Utrecht
Rheumatology & Clin. Immunology
De Bilt, Netherlands
Zuyderland Medisch Centrum Stichting
Rheumatology
Heerlen, Netherlands
Sponsor: University Medical Center Utrecht
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.